Literature DB >> 20675069

Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.

Sigurd Folkvord1, Kjersti Flatmark, Svein Dueland, Rik de Wijn, Krystyna Kotanska Grøholt, Knut H Hole, Jahn M Nesland, Rob Ruijtenbeek, Piet J Boender, Marianne Johansen, Karl-Erik Giercksky, Anne Hansen Ree.   

Abstract

PURPOSE: Tumor response of rectal cancer to preoperative chemoradiotherapy (CRT) varies considerably. In experimental tumor models and clinical radiotherapy, activity of particular subsets of kinase signaling pathways seems to predict radiation response. This study aimed to determine whether tumor kinase activity profiles might predict tumor response to preoperative CRT in locally advanced rectal cancer (LARC). METHODS AND MATERIALS: Sixty-seven LARC patients were treated with a CRT regimen consisting of radiotherapy, fluorouracil, and, where possible, oxaliplatin. Pretreatment tumor biopsy specimens were analyzed using microarrays with kinase substrates, and the resulting substrate phosphorylation patterns were correlated with tumor response to preoperative treatment as assessed by histomorphologic tumor regression grade (TRG). A predictive model for TRG scores from phosphosubstrate signatures was obtained by partial-least-squares discriminant analysis. Prediction performance was evaluated by leave-one-out cross-validation and use of an independent test set.
RESULTS: In the patient population, 73% and 15% were scored as good responders (TRG 1-2) or intermediate responders (TRG 3), whereas 12% were assessed as poor responders (TRG 4-5). In a subset of 7 poor responders and 12 good responders, treatment outcome was correctly predicted for 95%. Application of the prediction model on the remaining patient samples resulted in correct prediction for 85%. Phosphosubstrate signatures generated by poor-responding tumors indicated high kinase activity, which was inhibited by the kinase inhibitor sunitinib, and several discriminating phosphosubstrates represented proteins derived from signaling pathways implicated in radioresistance.
CONCLUSIONS: Multiplex kinase activity profiling may identify functional biomarkers predictive of tumor response to preoperative CRT in LARC. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675069     DOI: 10.1016/j.ijrobp.2010.04.036

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  29 in total

Review 1.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients.

Authors:  Kristina Schee; Kjersti Flatmark; Ruth Holm; Kjetil Boye; Elisabeth Paus
Journal:  Tumour Biol       Date:  2011-10-18

Review 3.  Deciphering enzyme function using peptide arrays.

Authors:  Alexandra Thiele; Gabriele I Stangl; Mike Schutkowski
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

Review 4.  Personalized radiotherapy: concepts, biomarkers and trial design.

Authors:  A H Ree; K R Redalen
Journal:  Br J Radiol       Date:  2015-05-20       Impact factor: 3.039

5.  Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Authors:  Kathrine Røe; Lars Tg Mikalsen; Albert J van der Kogel; Johan Bussink; Heidi Lyng; Anne H Ree; Laure Marignol; Dag R Olsen
Journal:  Radiat Oncol       Date:  2012-05-23       Impact factor: 3.481

6.  MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Cristina Caramés; Ion Cristóbal; Víctor Moreno; Laura del Puerto; Irene Moreno; María Rodriguez; Juan P Marín; Andrea V Correa; Roberto Hernández; Víctor Zenzola; Tatiana Hernández; Ana León; José I Martín; Paloma Sánchez-Fayos; Damián García-Olmo; Federico Rojo; Ajay Goel; María J Fernandez-Aceñero; Jesús García-Foncillas
Journal:  Int J Colorectal Dis       Date:  2015-05-08       Impact factor: 2.571

7.  Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma.

Authors:  Marie Grøn Saelen; Anne Hansen Ree; Alexandr Kristian; Karianne Giller Fleten; Torbjørn Furre; Helga Helseth Hektoen; Kjersti Flatmark
Journal:  Radiat Oncol       Date:  2012-09-27       Impact factor: 3.481

8.  Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.

Authors:  Marie Grøn Saelen; Kjersti Flatmark; Sigurd Folkvord; Rik de Wijn; Heidi Rasmussen; Øystein Fodstad; Anne Hansen Ree
Journal:  Angiogenesis       Date:  2011-08-11       Impact factor: 9.596

9.  Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer.

Authors:  Kathrine Røe; Åse Bratland; Ljiljana Vlatkovic; Harald Bull Ragnum; Marie Grøn Saelen; Dag Rune Olsen; Laure Marignol; Anne Hansen Ree
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

10.  Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancer.

Authors:  Anne Hansen Ree; Annette Torgunrud Kristensen; Marie Grøn Saelen; Rik de Wijn; Hege Edvardsen; Jovana Jovanovic; Torveig Weum Abrahamsen; Svein Dueland; Kjersti Flatmark
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.